If the patient chooses to participate, the patient and Investigator must both sign the Informed Consent Form. One copy will be given to the patient and the original must be documented in the medical source documents. In this study, the informed consent will have to be signed after surgery but before treatment start. 5.4.2 Patient eligibility For trial entry, all patients must fulfil all the inclusion criteria, described under Section 3.3.1. No patient with any exclus ion criterion from the list described in Section 3.3.2 may participate. To assure compliance with the entry criteria, all the assessments described in Sections 5.4.3 to 5.4.5 must be completed at screening to determine the patients’ eligibility for entry into the trial. 5.4.3 Demographic data, medical history A medical history (for details see below), including demographics, and physical examin ation of the patient must be completed during the 7 days prior to GM -CSF/TG01 1 st dose. Data to be collected at the screening examination are as listed below: • Medical History of pancreatic cancer o date of initial diagnosis o stage of disease at diagnosis o Date(s) of surgery and exten t of resection (R0 or R1) • Concomitant non- malignant diseases and treatments • All concomitant medications • Medications taken within the 4 weeks prior to enrolment • Patients’ procreative potential and contraceptive use must be documente d. For childbearing potential/fertile women, a pregnancy test is to be done within 7 days prior to the start of treatment and results are to be documented (serum or urine testing is acceptable) . 5.4.4 Special examinations • Tumour samples for KRAS status determin ation will be collected at surgery for analysis at the local laboratory • ECG within 7 days of start of Study Drugs (as detailed in section 5.9.3) and then if clinically indicated • CT-scan after surgery A report of th e examinations is to be made available in the patient’s source documents for the trial. CT TG01 -01 Version v 10.0 27 June 2018 Confidential 61 / 87 5.4.5 Physical examination A full p hysical examination will be performed and must include a complete, organ- oriented physical examination of the patient (i.e.